You are seeing this message because your Web browser does not support basic Web standards. Find out more about why this message is appearing and what you can do to make your experience on this site better.


ABOUT JAMA
Advanced Search

Welcome   | My Account | E-mail Alerts | Access Rights | Sign In


  Vol. 262 No. 13, October 6, 1989 TABLE OF CONTENTS
  JAMA
  •  Online Features
  Special Communications
 This Article
 •References
 •Full text PDF
 •Send to a friend
 • Save in My Folder
 •Save to citation manager
 •Permissions
 Citing Articles
 •Citation map
 •Citing articles on HighWire
 •Contact me when this article is cited
 Related Content
 •Similar articles in JAMA
 Social Bookmarking
  Add to CiteULike Add to Connotea Add to Del.icio.us Add to Digg Add to Reddit Add to Technorati Add to Twitter What's this?

RU-486 as an Antiprogesterone Steroid

From Receptor to Contragestion and Beyond

Etienne-Emile Baulieu, MD, PhD

JAMA. 1989;262(13):1808-1814.


Abstract

The steroid RU-486 (mifepristone) is an antiprogesterone that works at the receptor level. It can interrupt pregnancy very early on (contragestion), mostly by interfering with the process of implantation and decidua function. It also may facilitate surgical evacuation of the uterus and certain difficult deliveries. It impedes ovulation when taken during the follicular phase. Also, RU-486 is the first antiglucocorticosteroid available for clinical use. It deserves further studies to assess its wide range of therapeutic potential.

(JAMA. 1989;262:1808-1814)



Author Affiliations

From the Lab Hormones, Institut National de la Santé et de la Recherche Médicale and Faculté de Médecine, Bicêtre, France.; Dr Baulieu is a consultant to Roussel-Uclaf, the manufacturer of RU-486.


Footnotes

Based on a lecture given at the presentation of the Albert Lasker Clinical Medical Research Award, New York, NY, September 27, 1989.

Reprint requests to INSERM U 33, Lab Hormones, 94275 Bicêtre, France.



Add to CiteULike CiteULike   Add to Connotea Connotea   Add to Del.icio.us Del.icio.us   Add to Digg Digg   Add to Reddit Reddit   Add to Technorati Technorati   Add to Twitter Twitter     What's this?

THIS ARTICLE HAS BEEN CITED BY OTHER ARTICLES

JAMA, Abortion, and Editorial Responsibility
Lundberg
JAMA 1998;280:740-740.
FULL TEXT  

Early Termination of Pregnancy with Mifepristone (RU 486) and the Orally Active Prostaglandin Misoprostol
Peyron et al.
NEJM 1993;328:1509-1513.
ABSTRACT | FULL TEXT  

The Many Faces of RU486: Tales of Situated Knowledges and Technological Contestations
Clarke and Montini
Science Technology Human Values 1993;18:42-78.
ABSTRACT  

Updating RU 486 Development
Baulieu
J Law Med Ethics 1992;20:154-156.
 

Acceptability of Mifepristone for Early Pregnancy Interruption
David
J Law Med Ethics 1992;20:188-194.
 

Beyond 'Abortion': RU-486 and the Needs of the Crisis Constituency
Regelson et al.
JAMA 1990;264:1026-1027.
ABSTRACT  

RU-486
Godefroid
JAMA 1990;263:947-947.
ABSTRACT  





HOME | CURRENT ISSUE | PAST ISSUES | TOPIC COLLECTIONS | CME | SUBMIT | SUBSCRIBE | HELP
CONDITIONS OF USE | PRIVACY POLICY | CONTACT US | SITE MAP
 
© 1989 American Medical Association. All Rights Reserved.